×
Back to Agenda
Session 1: Local and Multi-regional Clinical Development (Strategy and Implementation)
Session Chair(s)
Wei Zhang
SVP, Head of Medicine, Greater China
Boehringer Ingelheim, China
Speaker(s)
Ning Li, MD, PHD
Sanofi, China
Vice President, Head of Asia Regulatory and Medical Policy
Sample Size Considerations in Multi-regional Clinical Trials
Luyan Dai, PHD
Boehringer Ingelheim, Shanghai, China
Associate Director, Biostatistics
Scientific Rigor in the Design of Simultaneous Global Drug Development - From Regulatory and Practical Perspectives
Gang CHEN, PHD
Johnson & Johnson, China
Have an account?